Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kaisorn L Chaichana, Leon Pinheiro & Henry Brem. (2015) Delivery of Local Therapeutics to the brain: Working Toward Advancing Treatment for Malignant Gliomas. Therapeutic Delivery 6:3, pages 353-369.
Read now
Read now
Vidyalakshmi Chandramohan, Duane A Mitchell, Laura A Johnson, John H Sampson & Darell D Bigner. (2013) Antibody, T-cell and Dendritic Cell Immunotherapy for Malignant Brain Tumors. Future Oncology 9:7, pages 977-990.
Read now
Read now
Pasquale De Bonis, Giorgio Lofrese, Carmelo Anile, Angelo Pompucci, Vera Vigo & Annunziato Mangiola. (2013) Radioimmunotherapy for High-Grade Glioma. Immunotherapy 5:6, pages 647-659.
Read now
Read now
David A Reardon, Michael R Zalutsky & Darell D Bigner. (2007) Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients. Expert Review of Anticancer Therapy 7:5, pages 675-687.
Read now
Read now
David E Gerber & John Laterra. (2007) Emerging monoclonal antibody therapies for malignant gliomas. Expert Opinion on Investigational Drugs 16:4, pages 477-494.
Read now
Read now
Articles from other publishers (66)
Sayda Dhaouadi, Balkiss Bouhaouala-Zahar & Gertraud Orend. (2024) Tenascin-C targeting strategies in cancer. Matrix Biology 130, pages 1-19.
Crossref
Crossref
Elena Obrador, Paz Moreno-Murciano, María Oriol-Caballo, Rafael López-Blanch, Begoña Pineda, Julia Gutiérrez-Arroyo, Alba Loras, Luis Gonzalez-Bonet, Conrado Martinez-Cadenas, José Estrela & María Marqués-Torrejón. (2024) Glioblastoma Therapy: Past, Present and Future. International Journal of Molecular Sciences 25:5, pages 2529.
Crossref
Crossref
Wujun Chen, Yudong Wu, Jie Wang, Wanpeng Yu, Xin Shen, Kai Zhao, Bing Liang, Xiaokun Hu, Shuai Wang, Hongfei Jiang, Xinlin Liu, Miao Zhang, Xiaohui Xing, Chao Wang & Dongming Xing. (2024) Clinical advances in TNC delivery vectors and their conjugate agents. Pharmacology & Therapeutics 253, pages 108577.
Crossref
Crossref
Majid Assadi, Reza Nemati, Hossein Shooli & Hojjat Ahmadzadehfar. 2024. Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum. Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum
109
125
.
Liang Zhang, Yuzhen Wang, Kristoff T. Homan, Stephanie M. Gaudette, Andrew J. McCluskey, Ying Chan, Joanne Murphy, Mary Abdalla, Christine M. Nelson, Victor Z. Sun, Jamie E. Erickson, Heather L. Knight, Anca Clabbers, Annette J. Schwartz Sterman & Soumya Mitra. (2022) Imaging the Alternatively Spliced D Domain of Tenascin C in a Preclinical Model of Inflammatory Bowel Disease. Molecular Imaging and Biology 25:2, pages 314-323.
Crossref
Crossref
Catarina I.G. Pinto, Joana F. Guerreiro, Francisco Silva, Filipa Mendes & António Paulo. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma
667
705
.
C.S. Bal & Geetanjali Arora. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma
613
630
.
Maria Cristina Oliveira & João D. G. Correia. (2022) Clinical application of radioiodinated antibodies: where are we?. Clinical and Translational Imaging 10:2, pages 123-162.
Crossref
Crossref
Sagun Parakh, Sze Ting Lee, Hui K. Gan & Andrew M. Scott. (2022) Radiolabeled Antibodies for Cancer Imaging and Therapy. Cancers 14:6, pages 1454.
Crossref
Crossref
Shailendra K. Gautam, Vipin Dalal, Maneesh Jain & Surinder K. Batra. 2022. Systemic Drug Delivery Strategies. Systemic Drug Delivery Strategies
437
461
.
L. Krolicki, J. Kunikowska, F. Bruchertseifer, H. Koziara, A. Morgenstern, B. Krolicki, E. Rosiak, D. Pawlak & A. Merlo. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging
1
16
.
Sagun Parakh, Joseph Nicolazzo, Andrew M Scott & Hui Kong Gan. (2021) Antibody Drug Conjugates in Glioblastoma – Is There a Future for Them?. Frontiers in Oncology 11.
Crossref
Crossref
Sayda Dhaouadi, Rahma Ben Abderrazek, Thomas Loustau, Chérine Abou-Faycal, Ayoub Ksouri, William Erne, Devadarssen Murdamoothoo, Matthias Mörgelin, Andreas Kungl, Alain Jung, Sonia Ledrappier, Zakaria Benlasfar, Sandrine Bichet, Ruth Chiquet-Ehrismann, Ismaïl Hendaoui, Gertraud Orend & Balkiss Bouhaouala-Zahar. (2021) Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies. Frontiers in Immunology 12.
Crossref
Crossref
Sara Hanaei, Víctor Andrés Arrieta & Adam M. Sonabend. 2020. Cancer Immunology. Cancer Immunology
379
425
.
Ali Gholamrezanezhad, Hossein Shooli, Narges Jokar, Reza Nemati & Majid Assadi. (2019) Radioimmunotherapy (RIT) in Brain Tumors. Nuclear Medicine and Molecular Imaging 53:6, pages 374-381.
Crossref
Crossref
Clément Bailly, Aurelien Vidal, Coralie Bonnemaire, Françoise Kraeber-Bodéré, Michel Chérel, Amandine Pallardy, Caroline Rousseau, Emmanuel Garcion, Franck Lacoeuille, François Hindré, Samuel Valable, Myriam Bernaudin, Caroline Bodet-Milin & Mickaël Bourgeois. (2019) Potential for Nuclear Medicine Therapy for Glioblastoma Treatment. Frontiers in Pharmacology 10.
Crossref
Crossref
Hans-Jürgen Reulen, Eric Suero Molina, Reinhard Zeidler, Franz Josef Gildehaus, Guido Böning, Astrid Gosewisch & Walter Stummer. (2019) Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments. Acta Neurochirurgica 161:6, pages 1109-1124.
Crossref
Crossref
Lee S. Hwang, Daria Krivosheya & Michael A. Vogelbaum. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery
429
446
.
Niyanta N. Kumar, Michelle E. Pizzo, Geetika Nehra, Brynna Wilken-Resman, Sam Boroumand & Robert G. Thorne. (2018) Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches. Bioconjugate Chemistry 29:12, pages 3937-3966.
Crossref
Crossref
Hui K. Gan, Martin van den Bent, Andrew B. Lassman, David A. Reardon & Andrew M. Scott. (2017) Antibody–drug conjugates in glioblastoma therapy: the right drugs to the right cells. Nature Reviews Clinical Oncology 14:11, pages 695-707.
Crossref
Crossref
Rémy Gébleux, Marco Stringhini, Ruben Casanova, Alex Soltermann & Dario Neri. (2016) Non‐internalizing antibody–drug conjugates display potent anti‐cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix. International Journal of Cancer 140:7, pages 1670-1679.
Crossref
Crossref
Joseph Gerard Jurcic, Jeffrey Y.C. Wong, Susan J. Knox, Daniel R. Wahl, Todd L. Rosenblat & Ruby F. Meredith. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
399
418.e14
.
Hans-Juergen ReulenGabriele PoepperlClaudia GoetzFranz Joseph GildehausMichael Schmidt, Klaus TatschTorsten Pietsch, Theo Kraus & Walter Rachinger. (2015) Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. Journal of Neurosurgery 123:3, pages 760-770.
Crossref
Crossref
F. A. Verburg, R. Sweeney, H. Hänscheid, S. Dießl, I. Israel, M. Löhr, G. H. Vince, M. Flentje, C. Reiners & S. Samnick. (2018) Patients with recurrent glioblastoma multiforme. Nuklearmedizin 52:01, pages 36-42.
Crossref
Crossref
Ruby F. Meredith, Jeffrey Y.C. Wong & Susan J. Knox. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology
e22-1
e22-46
.
Kevin S. Chen & Duane A. Mitchell. 2012. Glioma. Glioma
121
141
.
Gabriele Pöpperl. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine
187
198
.
Katharina Frey, Michael Fiechter, Kathrin Schwager, Benedetta Belloni, Marjam J. Barysch, Dario Neri & Reinhard Dummer. (2011) Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions. Experimental Dermatology 20:8, pages 685-688.
Crossref
Crossref
John H. Heinzerling, Jaeho Cho & Hak Choy. 2012. Cancer Metastasis. Cancer Metastasis
612
621
.
Michael R. Zalutsky, David A. Reardon & Darell D. Bigner. 2010. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer
139
167
.
Tim Fugmann, Dario Neri & Christoph Roesli. (2010) DeepQuanTR: MALDI‐MS‐based label‐free quantification of proteins in complex biological samples. PROTEOMICS 10:14, pages 2631-2643.
Crossref
Crossref
Joanne E. Ayriss, Chien-Tsun Kuan, Susan T. Boulton, David A. Reardon & Darell D. Bigner. 2009. CNS Cancer. CNS Cancer
865
898
.
Duane A. Mitchell, Peter E. Fecci & John H. Sampson. (2008) Immunotherapy of malignant brain tumors. Immunological Reviews 222:1, pages 70-100.
Crossref
Crossref
Frits Aarts, Robert P. Bleichrodt, Wim J.G. Oyen & Otto C. Boerman. (2008)
Review:
Intracavitary Radioimmunotherapy to Treat Solid Tumors
. Cancer Biotherapy and Radiopharmaceuticals 23:1, pages 92-107.
Crossref
Crossref
Dragan Grabulovski & Dario Neri. 2008. Tumor Angiogenesis. Tumor Angiogenesis
491
509
.
Rod Balhorn, Saphon Hok, Patricia A. Burke, Felice C. Lightstone, Monique Cosman, Adam Zemla, Gary Mirick, Julie Perkins, Arutselvan Natarajan, Michele Corzett, Sally J. DeNardo, Huguette Albrecht, Jeff P. Gregg & Gerry L. DeNardo. (2007) Selective High-Affinity Ligand Antibody Mimics for Cancer Diagnosis and Therapy: Initial Application to Lymphoma/Leukemia. Clinical Cancer Research 13:18, pages 5621s-5628s.
Crossref
Crossref
D M Goldenberg & R M Sharkey. (2007) Novel radiolabeled antibody conjugates. Oncogene 26:25, pages 3734-3744.
Crossref
Crossref
David M. Goldenberg, Jean-Francois Chatal, Jacques Barbet, Otto Boerman & Robert M. Sharkey. (2007) Cancer imaging and therapy with bispecific antibody pretargeting. Update on Cancer Therapeutics 2:1, pages 19-31.
Crossref
Crossref
Jascha‐N. Rybak, Eveline Trachsel, Jörg Scheuermann & Dario Neri. (2006) Ligand‐Based Vascular Targeting of Disease. ChemMedChem 2:1, pages 22-40.
Crossref
Crossref
Andreas Jordan & Klaus Maier-Hauff. 2007. Regional Cancer Therapy. Regional Cancer Therapy
379
393
.
Eveline Trachsel & Dario Neri. (2006) Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis. Advanced Drug Delivery Reviews 58:5-6, pages 735-754.
Crossref
Crossref
Simon S. Brack, Michela Silacci, Manfred Birchler & Dario Neri. (2006) Tumor-Targeting Properties of Novel Antibodies Specific to the Large Isoform of Tenascin-C. Clinical Cancer Research 12:10, pages 3200-3208.
Crossref
Crossref
Jennifer L. Snow, Peter Lloyd Jones & Darren B. Taichman. 2006. Pulmonary Vascular Disease. Pulmonary Vascular Disease
33
49
.
Raymond M. Reilly. 2005. Modern Biopharmaceuticals. Modern Biopharmaceuticals
497
535
.
Dario Neri & Roy Bicknell. (2005) Tumour vascular targeting. Nature Reviews Cancer 5:6, pages 436-446.
Crossref
Crossref
Florence Lefranc, Jacques Brotchi & Robert Kiss. (2005) Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis. Journal of Clinical Oncology 23:10, pages 2411-2422.
Crossref
Crossref
Claudia Maria Goetz, Walter Rachinger, Markus Decker, Franz-Josef Gildehaus, Susanne Stocker, Gundram Jung, Klaus Tatsch, J�rg-Christian Tonn & Hans-J�rgen Reulen. (2004) Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats. Cancer Immunology, Immunotherapy 54:4, pages 337-344.
Crossref
Crossref
Barbara Gonzalez Navarro, Angel Casacó Parada, Pio Alvarez, Avelina Leon, Edilis Santana, Ana Bada, Rene Figueredo, Normando Iznaga-Escobar & Rolando Perez. (2005) Local and systemic toxicity of h-R3, an anti-epidermal growth factor receptor monoclonal antibody, labeled with 188osmiun after the intracerebral administration in rats. Experimental and Toxicologic Pathology 56:4-5, pages 313-319.
Crossref
Crossref
Christof Seidl, Hedwig Schr�ck, Sabine Seidenschwang, Roswitha Beck, Ernst Schmid, Michael Abend, Karl-Friedrich Becker, Christos Apostolidis, Tuomo K. Nikula, Elisabeth Kremmer, Markus Schwaiger & Reingard Senekowitsch-Schmidtke. (2004) Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death. European Journal of Nuclear Medicine and Molecular Imaging 32:3, pages 274-285.
Crossref
Crossref
D. Pinilla-Arias, O. Mateo-Sierra, F.A. Gutiérrez, C. Fernández-Carballal & R. Carrillo. (2005) Inmunoterapia en astrocitomas de alto grado: principios y estado actual. Neurocirugía 16:4, pages 345-358.
Crossref
Crossref
Moneeb EhteshamKeith L. Black & John S. Yu. (2017) Recent Progress in Immunotherapy for Malignant Glioma: Treatment Strategies and Results from Clinical Trials. Cancer Control 11:3, pages 192-207.
Crossref
Crossref
DHY Shen, DK Marsee, J Schaap, W Yang, J-Y Cho, G Hinkle, HN Nagaraja, RT Kloos, RF Barth & SM Jhiang. (2004) Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy. Gene Therapy 11:2, pages 161-169.
Crossref
Crossref
Ruth Chiquet-Ehrismann & Matthias Chiquet. (2003) Tenascins: regulation and putative functions during pathological stress. The Journal of Pathology 200:4, pages 488-499.
Crossref
Crossref
Yang LiuKa-Yun NgKevin O. Lillehei. (2017) Cell-Mediated Immunotherapy: A New Approach to the Treatment of Malignant Glioma. Cancer Control 10:2, pages 138-147.
Crossref
Crossref
M. Ravic. 2003. Local Therapies for Glioma Present Status and Future Developments. Local Therapies for Glioma Present Status and Future Developments
77
82
.
C. Goetz, W. Rachinger, G. Poepper, M. Decker, F.-J. Gildehaus, S. Stocker, G. Jung, K. Tatsch, J.-C. Tonn & H.-J. Reulen. 2003. Local Therapies for Glioma Present Status and Future Developments. Local Therapies for Glioma Present Status and Future Developments
69
75
.
John E. Lahaniatis & Luther W. Brady. 2003. Combined Modality Therapy of Central Nervous System Tumors. Combined Modality Therapy of Central Nervous System Tumors
449
452
.
Peter E Fecci & John H Sampson. (2002) Clinical immunotherapy for brain tumors. Neuroimaging Clinics of North America 12:4, pages 641-664.
Crossref
Crossref
Jorge L. Eller, Sharon L. Longo, Daniel J. Hicklin & Gregory W. Canute. (2002) Activity of Anti-epidermal Growth Factor Receptor Monoclonal Antibody C225 against Glioblastoma Multiforme. Neurosurgery 51:4, pages 1005-1014.
Crossref
Crossref
Jorge L. Eller, Sharon L. Longo, Daniel J. Hicklin & Gregory W. Canute. (2002) Activity of Anti-epidermal Growth Factor Receptor Monoclonal Antibody C225 against Glioblastoma Multiforme. Neurosurgery 51:4, pages 1005-1014.
Crossref
Crossref
Giuseppe Viale, Alessandra Dorcaratto, Patrizia Castellani & Laciano Zardi. (2002) Tenascin-C in astrocytic tumors. Surgical Neurology 57:4, pages 286.
Crossref
Crossref
Ganesan Vaidyanathan, Donna J. Affleck, Darell D. Bigner & Michael R. Zalutsky. (2002) Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate. Nuclear Medicine and Biology 29:1, pages 1-11.
Crossref
Crossref
Brian J. Hicke, Chris Marion, Ying-Fon Chang, Ty Gould, Cynthia K. Lynott, David Parma, Paul G. Schmidt & Steve Warren. (2001) Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein. Journal of Biological Chemistry 276:52, pages 48644-48654.
Crossref
Crossref
Nisha Virasch & Carol A. Kruse. (2001) STRATEGIES USING THE IMMUNE SYSTEM FOR THERAPY OF BRAIN TUMORS. Hematology/Oncology Clinics of North America 15:6, pages 1053-1072.
Crossref
Crossref
Kim Kramer & Nai-Kong V. Cheung. (2001) Antibody-based diagnostic and therapeutic innovations for human cancer. Comprehensive Therapy 27:3, pages 183-194.
Crossref
Crossref
Frederick Scheetz Jones & Peter Lloyd Jones. (2000) The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Developmental Dynamics 218:2, pages 235-259.
Crossref
Crossref